Stay updated on Aldesleukin and Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Aldesleukin and Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Aldesleukin and Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6. This indicates a page rendering/software update rather than any changes to the study details or data.
    Difference
    0.1%
    Check dated 2026-08-30T21:57:06.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision metadata updated to v3.6.5, indicating a backend/software update; no observable changes to the study details.
    Difference
    0.0%
    Check dated 2026-08-09T08:46:33.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page's footer revision label changed from v3.6.3 to v3.6.4, indicating a new deployment version of the page. No study content or data was modified.
    Difference
    0.0%
    Check dated 2026-07-25T17:10:46.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The page's footer revision label was updated from v3.6.2 to v3.6.3, indicating a small software update rather than changes to study information.
    Difference
    0.0%
    Check dated 2026-07-04T04:12:29.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous v3.6.0. This indicates a maintenance/template update rather than a change to the study details or visible content.
    Difference
    0.0%
    Check dated 2026-06-27T02:06:50.000Z thumbnail image
  9. Check
    92 days ago
    Change Detected
    Summary
    The study page now displays a 'No longer looking for participants' notice indicating recruitment has closed and adds new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment header formatting was updated and the revision label changed from v3.5.5 to v3.6.0.
    Difference
    0.5%
    Check dated 2026-06-12T16:25:02.000Z thumbnail image

Stay in the know with updates to Aldesleukin and Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Aldesleukin and Pembrolizumab in Melanoma Clinical Trial page.